Effects of glutamine supplements and radiochemotherapy on systemic immune and gut barrier function in patients with advanced esophageal cancer
This 1998 clinical trial evaluated the impact of oral glutamine supplementation (30 g/day for 28 days) on immune and gut barrier function in 13 patients with advanced esophageal cancer undergoing radiochemotherapy (5-fluorouracil and cisplatin with mediastinal irradiation). Compared to controls, the glutamine group maintained higher lymphocyte counts (1007 ± 151/mm³
June 26, 2025
No Comments